Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 01-2022 | 10-2021 | 07-2021 | 04-2021 | 01-2021 | |
| Operating Expenses | 26,683 | 23,603 | 19,516 | 0 | 12,657 |
| Operating Income | -26,683 | -23,603 | -19,516 | N/A | -12,657 |
| Other Income | 4,216 | 3,953 | 3,407 | 0 | 2,609 |
| Pre-tax Income | -22,467 | -19,650 | -16,109 | 0 | -10,048 |
| Net Income Continuous | -22,467 | -19,650 | -16,109 | N/A | -10,048 |
| Net Income | $-22,467 | $-19,650 | $-16,109 | $N/A | $-10,048 |
| EPS Basic Total Ops | -0.92 | -0.80 | -0.66 | N/A | -0.56 |
| EPS Basic Continuous Ops | -0.92 | -0.80 | -0.66 | N/A | -0.56 |
| EPS Diluted Total Ops | -0.92 | -0.80 | -0.66 | N/A | -0.56 |
| EPS Diluted Continuous Ops | -0.92 | -0.80 | -0.66 | N/A | -0.56 |
| EBITDA(a) | $-25,674 | $-22,959 | $-19,516 | $N/A | $-12,013 |